Otonomy Announces FDA Acceptance of AuriPro(TM) New Drug Application
28 avr. 2015 07h00 HE
|
Otonomy, Inc.
SAN DIEGO, April 28, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...